189 related articles for article (PubMed ID: 16553952)
1. Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency.
McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
Health Qual Life Outcomes; 2006 Mar; 4():16. PubMed ID: 16553952
[TBL] [Abstract][Full Text] [Related]
2. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency.
McMillan CV; Bradley C; Gibney J; Healy ML; Russell-Jones DL; Sönksen PH
Clin Endocrinol (Oxf); 2003 Oct; 59(4):467-75. PubMed ID: 14510909
[TBL] [Abstract][Full Text] [Related]
3. Preliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: the A-RHDQoL.
McMillan CV; Bradley C; Giannoulis M; Martin F; Sönksen PH
Health Qual Life Outcomes; 2003 Oct; 1():51. PubMed ID: 14613571
[TBL] [Abstract][Full Text] [Related]
4. Development of the Well-being questionnaire short-form in Japanese: the W-BQ12.
Riazi A; Bradley C; Barendse S; Ishii H
Health Qual Life Outcomes; 2006 Jul; 4():40. PubMed ID: 16817960
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two health status measures in adults with growth hormone deficiency.
McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):436-45. PubMed ID: 12641626
[TBL] [Abstract][Full Text] [Related]
6. Preliminary development of the new individualized HDQoL questionnaire measuring quality of life in adult hypopituitarism.
McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
J Eval Clin Pract; 2006 Oct; 12(5):501-14. PubMed ID: 16987112
[TBL] [Abstract][Full Text] [Related]
7. Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis.
Deijen JB; Arwert LI; Witlox J; Drent ML
Health Qual Life Outcomes; 2005 Oct; 3():63. PubMed ID: 16236167
[TBL] [Abstract][Full Text] [Related]
8. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.
Peker Y; Svensson J; Hedner J; Grote L; Johannsson G
Clin Endocrinol (Oxf); 2006 Jul; 65(1):98-105. PubMed ID: 16817827
[TBL] [Abstract][Full Text] [Related]
9. Assessing the psychometric characteristics of the Macedonian version of the Oral Health Impact Profile questionnaire (OHIP-MAC49).
Kenig N; Nikolovska J
Oral Health Dent Manag; 2012 Mar; 11(1):29-38. PubMed ID: 22488030
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.
Chiba R; Miyamoto Y; Kawakami N
Int J Nurs Stud; 2010 Mar; 47(3):314-22. PubMed ID: 19679304
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
[TBL] [Abstract][Full Text] [Related]
13. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
14. The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF.
da Rocha NS; Power MJ; Bushnell DM; Fleck MP
Value Health; 2012 May; 15(3):449-57. PubMed ID: 22583455
[TBL] [Abstract][Full Text] [Related]
15. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults.
Gilchrist FJ; Murray RD; Shalet SM
Clin Endocrinol (Oxf); 2002 Sep; 57(3):363-70. PubMed ID: 12201829
[TBL] [Abstract][Full Text] [Related]
16. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
17. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
[TBL] [Abstract][Full Text] [Related]
18. Psychological well-being of gynecologic and obstetric patients: a validation of the 12-item Well-Being Questionnaire (W-BQ12).
Watrowski R; Rohde A
Wien Klin Wochenschr; 2014 Sep; 126(17-18):524-31. PubMed ID: 24993305
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
20. Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement.
Lewandowski KC; Murray RD; Drzewoski J; O'Callaghan CJ; Czupryniak L; Hillhouse EW; Shalet SM; Randeva HS
Mol Genet Metab; 2003 Nov; 80(3):330-7. PubMed ID: 14680980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
